揭示差距：重症哮喘患者呼出一氧化氮分数与生物疗法的临床反应性--一项回顾性研究。

IF 4.3 3区医学 Q1 RESPIRATORY SYSTEM

ERJ Open Research Pub Date : 2024-09-23 eCollection Date: 2024-09-01 DOI:10.1183/23120541.00296-2024

Mauro Maniscalco, Claudio Candia, Dina Visca, Maria D'Amato, Cecilia Calabrese, Pasquale Ambrosino, Antonio Molino, Salvatore Fuschillo

引用次数: 0

摘要

在接受生物药物治疗的重症哮喘患者中，有一部分人的 F ENO 显著下降。然而，F ENO 的变化在很大程度上与生物药物治疗的临床疗效无关。https://bit.ly/3xWszYJ。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Revealing the gap: fractional exhaled nitric oxide and clinical responsiveness to biological therapy in severe asthma - a retrospective study.

A proportion of patients with severe asthma treated with biological drugs undergoes a significant decline in F _ENO. However, variations in F _ENO are largely independent of the clinical efficacy of the biological drug therapy. https://bit.ly/3xWszYJ.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

ERJ Open Research Medicine-Pulmonary and Respiratory Medicine

CiteScore

6.20

自引率

4.30%

发文量

273

审稿时长

8 weeks

期刊介绍： ERJ Open Research is a fully open access original research journal, published online by the European Respiratory Society. The journal aims to publish high-quality work in all fields of respiratory science and medicine, covering basic science, clinical translational science and clinical medicine. The journal was created to help fulfil the ERS objective to disseminate scientific and educational material to its members and to the medical community, but also to provide researchers with an affordable open access specialty journal in which to publish their work.